FDA Drug Application (202564) for CLINDAMYCIN PHOSPHATE AND TRETINOIN by ACTAVIS MID ATLANTIC

Back to FDA Applications sponsored by ACTAVIS MID ATLANTIC

Application Number202564
Product Number001
FormGEL;TOPICAL
Dosage1.2%;0.025%
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameCLINDAMYCIN PHOSPHATE AND TRETINOIN
Active IngredientCLINDAMYCIN PHOSPHATE; TRETINOIN

Active IngredientCount
List of drugs with Active Ingredient CLINDAMYCIN PHOSPHATE21
List of drugs with Active Ingredient TRETINOIN13


Back to FDA Applications sponsored by ACTAVIS MID ATLANTIC